Paragon Care (ASX:PGC): What Do FY26 Revenue and Statutory Earnings Reveal?

Aditi Sarkar

02 November 2026 06:10 PM AEDT

Paragon Care (ASX:PGC): What Do FY26 Revenue and Statutory Earnings Reveal?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

FY26 statutory Revenue reached approximately AUD 3.7 billion, increasing 1.8%.
Underlying EBITDA was AUD 97.2 million, while the statutory net result was a loss.
Integration, working-capital efficiency and financing remain key issues.

Paragon Care Limited distributes and manufactures healthcare products and medical equipment across Asia Pacific, supplying hospitals, clinics and other healthcare customers. Its activities encompass pharmaceuticals, medical consumables, devices and specialised clinical products. Paragon Care (ASX:PGC) shares closed at AUD 0.155 on 2 November 2026. Its 2026 disclosures described an expanded distribution business, modest underlying Earnings growth and a statutory loss, with integration and financial management remaining central operating issues.

FY26 reported and underlying results

Paragon Care (ASX:PGC) reported statutory revenue of AUD 3.7 billion for the year ended 30 June 2026, an increase of 1.8% year on year. Underlying EBITDA was AUD 97.2 million, an increase of 2.1%. However, statutory EBITDA declined 42.6% to AUD 50.8 million and the company reported a statutory net loss after tax of AUD 16.0 million. Normalised revenue growth was reported at 6.7%. Each measure uses a different basis and should not be treated as interchangeable.

The gap between underlying and statutory earnings is relevant for Paragon Care (ASX:PGC) because integration, restructuring and other adjustments may affect the ultimate return from its distribution footprint. A positive underlying EBITDA figure is not the same as cash available after financing costs and Capital expenditure. The September audited release confirmed no changes to the reported profit and key Balance Sheet totals compared with the preliminary report.

Distribution and operational considerations

Paragon Care (ASX:PGC) serves healthcare customers through wholesale, distribution and Manufacturing operations. A substantial revenue base can involve considerable purchasing, storage, transport and working-capital requirements. Inventory availability and fulfilment reliability therefore affect Customer Service and cash use. The Business model also depends on supplier relationships, healthcare procurement arrangements and managing the cost of logistics.

During 2026 the company published its audited results, announced an on-market share buy-back and disclosed a chief financial officer appointment. These are distinct corporate developments and do not establish the timing or magnitude of future earnings changes. Paragon Care (ASX:PGC) must continue managing integration across its broad product and customer network while maintaining distribution standards.

Risks, Liquidity and priorities

A healthcare wholesaler may report substantial revenue without translating the same proportion into profit because product purchasing, labour, Warehousing and financing costs absorb cash. Paragon Care (ASX:PGC) faces risks from inventory management, customer concentration, supplier terms, competition, integration complexity and Debt obligations. Statutory earnings Volatility also warrants attention when comparing reporting periods.

Subsequent reporting can be assessed through underlying and statutory margins, working capital, operating cash flow, interest costs and any further changes to financing. The distinction between growth in sales and cash generation is particularly important for Paragon Care (ASX:PGC).

There is also a distinction between an announced share buy-back and the actual Volume of shares subsequently repurchased. Capital allocation choices need to be considered alongside debt service, inventory requirements and other commitments. In a large-scale distribution operation, modest shifts in payment timing or stockholding can have meaningful implications for cash flow even without a corresponding change in reported revenue.

Key Insights

The 2026 disclosures show that Paragon Care Limited (ASX:PGC) must be evaluated through operating performance, financing and execution together. Its business-specific developments create measurable reporting milestones, while published results describe actual outcomes rather than guaranteed future progress. The next financial updates will clarify how operations and cash requirements evolve.

Financial analysis requires attention to the reporting basis and period used for each figure. Operating measures and statutory results can differ because of adjustments, while movements in debt and cash may arise at different points in the year. A direct comparison of those measures helps assess the quality of the reported outcome without assuming the next period will repeat it.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.